Artemis US Extended Alpha Fund I Acc GBP
Category US Large-Cap Growth Equity
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price
£5.0736
£0.047 (+0.94%)
Fund Code
ATUAA
BMMV5G5
GB00BMMV5G59
Prices updated as at 12 Dec 2025
Prices in GBP
Investment objective
The objective of the fund is to grow capital over a five year period. The fund invests at least 80% in shares of US companies, either directly or indirectly through derivatives and Up to 20% in shares, or derivatives of shares, of companies in other countries, bonds, cash, near cash, other transferable securities, other funds (up to 10%) managed by Artemis and third party funds, and money market instruments.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.
- Key stats
- Growth
- Performance
- Charges & documents
- Dividends
- Portfolio
- Risk & rating
- Management
Annual performance (%)
| Year | This fund | US Large-Cap Growth Equity |
|---|---|---|
| 30 Sep 14 - 30 Sep 15 | 11.64 | 6.15 |
| 30 Sep 15 - 30 Sep 16 | 36.05 | 28.51 |
| 30 Sep 16 - 30 Sep 17 | 18.16 | 15.24 |
| 30 Sep 17 - 30 Sep 18 | 20.24 | 24.80 |
| 30 Sep 18 - 30 Sep 19 | 11.08 | 8.08 |
| 30 Sep 19 - 30 Sep 20 | 10.42 | 24.11 |
| 30 Sep 20 - 30 Sep 21 | 22.82 | 22.62 |
| 30 Sep 21 - 30 Sep 22 | -0.93 | -8.23 |
| 30 Sep 22 - 30 Sep 23 | 9.96 | 11.67 |
| 30 Sep 23 - 30 Sep 24 | 22.88 | 22.60 |
| 30 Sep 24 - 30 Sep 25 | 10.18 | 18.07 |
Trailing returns (%)
| Year | This fund | US Large-Cap Growth Equity |
|---|---|---|
| 1 Day | 0.94 | -0.13 |
| 1 Month | -1.59 | -2.45 |
| 3 Months | 7.39 | 3.50 |
| 6 Months | 17.71 | 12.94 |
| 1 Year | 5.28 | 5.26 |
| 3 Years annualised | 17.14 | 19.69 |
| 5 Years annualised | 12.34 | 9.82 |
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.